Axonal and dendritic outgrowth are fundamental processes in the development of the nervous system. During this period, neurons change their morphology from a simple bipolar shape into a mature complex shape. Neurons develop dendrites and extend long or short axons that travel through a complex path until reaching target cells and form functional and accurate neuronal circuits. Throughout the way, dendrites and axons interact with several extracellular guidance cues (**[Figure 1](#F1){ref-type="fig"}**), among which are adhesive molecules, either from the extracellular matrix or the surface of nearby cells, as well as diffusible chemotropic molecules that are secreted to the extracellular milieu (Maeda, 2015). Axonal interaction with extracellular guidance cues is possible because on the distal tip of the axon there is a specialized, highly dynamic and motile structure, called the growth cone. Dendrites also possess similar structures. Growth cones contain several different receptors on its membrane surface, as well as cell adhesion molecules that interact with those signalling cues present in the extracellular space, resulting in the activation of signalling cascades and consequent regulation of the cytoskeleton structure (Lowery and Van Vactor, 2009). Signalling cues can function as either attractants or repellents, promoting or inhibiting neurite growth, regulating neurite pathfinding, and neuronal arborisation. These different functions depend not only on the cue, but mostly on the receptor repertoire that is present and activated at each moment, as well as on the intracellular signalling cascades available to be activated in the growth cones (Kaplan et al., 2014; Maeda, 2015). Activation of these receptors will induce a rearrangement of the cytoskeleton thus promoting changes in neuronal morphology. As examples of diffusible chemotropic cues are morphogens and growth/neurotrophic factors such as brain-derived neurotrophic factor (BDNF). BDNF is widely expressed in the adult brain, and particularly highly expressed in the developing brain. This neurotrophin is released by neurons, microglia and astrocytes, and is involved not only in nervous system development, including the regulation of neuronal outgrowth, such as in dendritic and axonal growth and arborisation, but also in synaptic plasticity (Huang and Reichardt, 2001) and neuronal regeneration following peripheral and central nervous system injury (Huang and Reichardt, 2001; Ribeiro et al., 2015b). Synaptic actions of BDNF are modulated by adenosine, a purine nucleoside that is ubiquitously present in the brain and modulates several actions of other molecules, including synaptic activity (Sebastião and Ribeiro, 2009). During brain development, adenosine is highly expressed in the brain (Ribeiro et al., 2015b). Adenosine is released by neuronal cells during neuronal activity, being its intracellular concentration under the tight control of the activity of adenosine kinase. In the adult brain, this enzyme is mostly expressed in astrocytes, which plays a preponderant role in the levels of extracellular adenosine (Diógenes et al., 2014) since adenosine is released or taken up through equilibrative transporters located in the plasma membrane. Moreover, adenosine is also extracellularly generated from the hydrolysis of released adenine nucleotides. There are two high affinity adenosine receptors in the brain, the inhibitory A~1~ receptor (A~1~R) and the excitatory A~2A~ receptor (A~2A~R). These receptors are G-protein coupled receptors and are present in the whole brain, although their density varies in different brain regions (Sebastiāo and Ribeiro, 2009). The more widely known neuromodulatory actions of adenosine are the control of synaptic function by either interfering with neurotransmitter release or neurotransmitter action at synapses. By using cortical neurons in culture we recently explored a much less known adenosine action, its neurotrophic potential. Both A~2A~Rs and BDNF TrkB receptors are co-expressed during the development of primary cortical neurons (Ribeiro et al., 2015a). Considering the crosstalk between A~2A~Rs and TrkB receptors and the influence of BDNF upon neuronal outgrowth, we hypothesized that A~2A~Rs could have a role upon neuronal outgrowth. Remarkably, we could find out (Ribeiro et al., 2015a) that activation of A~2A~R promotes the elongation of the axon, as well as dendritic arborisation (**[Figure 2](#F2){ref-type="fig"}**), being the effect of axonal elongation independent of endogenous BDNF actions. On the other hand, A~2A~R activation enhances BDNF-dependent dendritic branching (Ribeiro et al., 2015a), which means that adenosine, through A~2A~R activation, is able to act in a synergistic way with BDNF to control its neurotrophic actions. Potentiation of BDNF actions may involve the cAMP/PKA signalling pathway (Diógenes et al., 2004) and facilitation of TrkB signalling through transactivation of TrkB receptors and/or TrkB translocation to lipid rafts (Assaife-Lopes et al., 2014) or even the stimulation of BDNF mRNA and protein expression, as well as secretion of BDNF protein to the extracellular space, which in turn will act on TrkB receptors and thus promote changes in neuronal morphology (Ribeiro et al., 2015b). There are pathologies, as depression, where a decrease in neuronal arborisation occurs and that are associated to a decrease in BDNF levels and/or to a decrease in the levels of the signalling receptor for BDNF, the TrkB receptor. Indeed, several antidepressants promote BDNF expression and thus neuronal branching. One may thus hypothesize that A~2A~R selective agonists, by promoting BDNF action on neuronal morphology, may prove a good strategy to attenuate depression.

![Migration of an axonal growth cone during brain development.\
The growth cones contain dynamic microtubules that allow the growth cone to grow and change direction, while the rest of the axon is composed of stable microtubules. During axonal migration, the growth cone interacts with several extracellular signalling cues that guide the growth cone to the target cell. Signalling cues can be adhesive molecules (blue background) that are part of the extracellular matrix or part of the surface of adjacent cells. The binding of these cues to adhesive molecules present on the surface of growth cones, contribute to the progression of the growth cone in the extracellular space. Antiadhesive molecules (red background), on the other hand, inhibit growth cone progression. Moreover, there are also diffusible attractant (green cycles) and repulsive (red cycles) signalling cues that are released by cells from a wider vicinity, and function as instructors to guide growth cones, one example is the neurotrophin brain-derived neurotrophic factor (BDNF), or, as our work suggests, adenosine, through adenosine A2A receptor activation. As a result of the interaction with extracellular signalling cues, the dynamics of growth cone cytoskeleton will be changed, which will have an impact on axonal growth and guidance.](NRR-11-706-g001){#F1}

![Adenosine A~2A~ receptor activation increases dendritic arborisation and axon extension.\
Adenosine A2A receptor activation by the selective agonist CGS 21680 enhances brain-derived neurotrophic factor (BDNF)-induced dendritic branching and promotes axonal elongation through mitogen-activated protein kinases (MAPK), phosphoinositide 3-kinase (PI3K) and phospholipase C (PLC) signalling pathways.](NRR-11-706-g002){#F2}

The ability of adenosine, through A~2A~R activation, to promote axonal elongation, is dependent on the activation of several signalling cascades known to be involved in the regulation of microtubule dynamics during axonal growth, such as phosphoinositide 3-kinase (PI3K), mitogen-activated protein kinases (MAPK) and phospholipase C (PLC) (Ribeiro et al., 2015a). Remarkably, these actions of adenosine are independent of BDNF (Ribeiro et al., 2015a). Adenosine may thus act as an extracellular guidance cue, directing the migration of axonal growth cones or even fine-tuning the actions of other cues. Indeed, A~2A~Rs are positively coupled to adenylate cyclase and cyclic AMP which has an important role in modulating the growth cone turning responses in the presence of guidance cues (Ribeiro et al., 2015b).

The cytoskeleton of the growth cone is highly dynamic, making possible the exploration of the surrounding environment and axon guidance towards the appropriate targets. It is mainly formed by microtubules coming along the axon and splaying in the centre of the growth cone, as well as by actin fibres present in filopodia and lamellipodia structures in the peripheral region of growth cones (Lowery and Van Vactor, 2009). Rearrangements of the cytoskeleton comprise changes in actin and microtubule assembly and dynamics. In fact, dynamic microtubules in the growth cones may function as detectors of extracellular conditions, thus favouring process elongation or retraction depending on the extracellular environment. Although several mediators are known to influence cytoskeleton rearrangements, the mechanisms behind the translation of the signalling cues into changes of the cytoskeletal machinery are largely unknown.

Microtubules are tubular structures composed of heterodimers of α- and β-tubulin. Axonal elongation is achieved through microtubule assembly of tubulin heterodimers to the microtubule plus ends. During the process of axon growth, microtubules undergo cycles of polymerization (growth) and depolymerisation (shortening) at microtubule plus ends in the growth cone, a process called dynamic instability (Lowery and Van Vactor, 2009). By transfecting rat primary cultured cortical neurons with a construct of end-binding protein 3 (EB3), we were able to label growing microtubule plus ends and to find that A~2A~R activation increases the microtubule growth speed (Ribeiro et al., 2015a). Moreover, the axon has regions with different microtubule stability, whose regulation allows the axon to grow, turn and stabilize its structure. Microtubule dynamics and stability are affected by several post-translational modifications of tubulin. For example, post-translational tyrosinated α-tubulin is normally associated with dynamic microtubules, whereas detyrosinated and acetylated α-tubulin is associated with stable microtubules (Fukushima et al., 2009). Activation of A~2A~Rs decrease the ratio acetylated α-tubulin/tyrosinated α-tubulin, which suggests an increase in microtubule dynamics that is central for microtubule extension and thus axonal growth (Ribeiro et al., 2015a). This is also consistent with reports showing that Gα subunit directly regulates the dynamic instability of microtubules required for neurite outgrowth, in a process independent of cAMP/PKA (Ribeiro et al., 2015b). Although we demonstrated that A~2A~Rs promote microtubule instability, how cytoskeletal dynamics is regulated by A~2A~R activation in a context of neurite outgrowth is still unclear. Whether this action of A~2A~Rs results from a direct interference of A~2A~R signalling cascades upon microtubules or through the action of other membrane signalling molecules also remains unknown. Nevertheless, as herein reviewed, evidences start to emerge that demonstrate the importance of adenosine, through A~2A~R activation, in processes of neuronal differentiation and neurite outgrowth, thus suggesting that A~2A~R play a trophic influence during neuronal maturation.

Signalling cues and cytoskeleton dynamics at the growth cones are not only important for neuronal outgrowth during development, but are also essential for neuronal regeneration. A~2A~Rs may thus constitute a target for the development of future strategies for neuronal regeneration. The use of selective A~2A~R agonists would be suitable to regenerate circuits after a brain injury, in which it is necessary to guide new axons and to re-establish the dendritic and axonal arbour. Moreover, it could be also promising in several pathologies that encompass neuronal atrophy, including psychiatric diseases such as depression. However, care has to be taken in situations where A~2A~Rs have their levels enhanced. With ageing and in conditions of psychiatric or neurologic diseases such as chronic stress, Parkinson\'s disease and Huntington\'s disease, the density of A~2A~Rs may be increased in some brain areas and its activation can be deleterious (Sebastiāo and Ribeiro, 2009). An example is the stress-induced atrophy of dendritic arborisation, which can be reverted by A~2A~R blockade (Batalha et al., 2012).

Altogether, these observations highlight a key role of A~2A~R in neuronal arborisation, where a fine tuning action of A~2A~R may occur as a function of neuronal development and activity. By shaping A~2A~R activity it may be possible to promote neuronal morphological changes with impact in the function of neuronal circuits. Further studies are however required to better understand the consequences and mechanisms underlying the A~2A~R-mediated neurotrophic actions in the different brain areas and under different pathophysiologic conditions.
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